ONESOURCE SPECIALTY PHARMA Q2 FY27
Net Profit: βΉ57 Cr β448% YoY | β130% QoQ
Revenue: βΉ516 Cr β37% YoY | β15% QoQ
Other Income: βΉ1 Cr vs βΉ3 Cr YoY | βΉ4 Cr QoQ
EPS: βΉ5.01 β445% YoY | β130% QoQ
Net Profit: βΉ57 Cr β448% YoY | β130% QoQ
Revenue: βΉ516 Cr β37% YoY | β15% QoQ
Other Income: βΉ1 Cr vs βΉ3 Cr YoY | βΉ4 Cr QoQ
EPS: βΉ5.01 β445% YoY | β130% QoQ
ONESOURCE SPECIALTY PHARMA Q2 FY27 (CONS.)
Net Profit: βΉ57.48 Cr β448.25% YoY | β129.96% QoQ
Revenue: βΉ516.24 Cr β37.39% YoY | β14.97% QoQ
EBITDA: βΉ163.29 Cr β53.33% YoY | β32.38% QoQ
EBITDA Margin: 31.63% vs 28.34% YoY | 27.47% QoQ
Net Profit: βΉ57.48 Cr β448.25% YoY | β129.96% QoQ
Revenue: βΉ516.24 Cr β37.39% YoY | β14.97% QoQ
EBITDA: βΉ163.29 Cr β53.33% YoY | β32.38% QoQ
EBITDA Margin: 31.63% vs 28.34% YoY | 27.47% QoQ
β€1
L&T: CO WINS MAJOR ORDER; MAJOR ORDER VALUES BETWEEN 5000 CR - 10000 CR RUPEES
BANDHAN BANK: FIRST ABU DHABI SAID TO BE IN TALKS WITH BANDHAN BANK FOR ACQUISTION
INDIA OIL MINISTER: INDIA IS NOW BUYING 67% OF LPG IMPORTS FROM US
π₯1
TARIL: CO. ANNOUNCES RS. 1,250 CRORE INVESTMENT IN THREE GREENFIELD MANUFACTURING PLANTS TO STRENGTHEN INDIA'S POWER INFRASTRUCTURE ECOSYSTEM AND CREATE 1,000+ DIRECT JOBS
TATA CONS, SUNIL D'SOUZA SAYS
International Biz Saw Mid-single Digit Growth
Growth In Tea Biz Will Return In H2
Will See Strong Double-digit Growth On The Topline Front
Entering Nutraceuticals Segment As Well
Dry Fruits & Cold Press Oils Biz Have Been Growing Faster Than Overall Growth Portfolio
Will Grow 25-30% With Capital Foods & Organic India
International Biz Saw Mid-single Digit Growth
Growth In Tea Biz Will Return In H2
Will See Strong Double-digit Growth On The Topline Front
Entering Nutraceuticals Segment As Well
Dry Fruits & Cold Press Oils Biz Have Been Growing Faster Than Overall Growth Portfolio
Will Grow 25-30% With Capital Foods & Organic India
β€1
KFIN TECH SAYS From Concall
Intl Biz Pipeline Stands At $47 m Today, Up From $20 m Last Year
Expect Domestic MF As A % Of Total AUM To Drop Below 50% Levels, Currently At 52%
Guiding For FY27 EBITDA Margin At 40%
Expect Expense Rationalisation Benefits To Continue In H2
Intl Biz Pipeline Stands At $47 m Today, Up From $20 m Last Year
Expect Domestic MF As A % Of Total AUM To Drop Below 50% Levels, Currently At 52%
Guiding For FY27 EBITDA Margin At 40%
Expect Expense Rationalisation Benefits To Continue In H2
MAHINDRA LIFESPACES: CO. TO DEVELOP 10.05-ACRE LAND PARCEL IN NORTH BENGALURU WITH RS. 1,250 CRORE GDV
VODAFONE IDEA: NET ADDED 550,119 MOBILE USERS SEPT VS 506,139 ADDED AUG
β€3
RELIANCE INDUSTRIES: RJIO NET ADDED 2.71 MLN MOBILE USERS SEPT VS 2.40 MLN ADDED AUG
β€4
PB FINTECH: IRDAI TO HEAR STAKEHOLDERSβ CONCERNS ON DISTRIBUTION REFORMS, SAYS CHAIRMAN
π₯1
AMAZON & TATA PARTNER TO BUILD CHARDING INFRA; AMAZON WILL BE ORDERING TRUCKS, TO DEPLOY AROUND 3500 TATA ELECTRIC TRUCKS ( TATA MOTORS )
β€1
TATA POWER: CO SIGNS MOU WITH BPCL TO DEVELOP 110 KV POWER INFRASTRUCTURE FOR ITS LANDMARK PRFCCU PROJECT AT MUMBAI REFINER
β€1
SKY GOLD & DIAMONDS Q2 FY27
Net Profit: βΉ129 Cr β93% YoY | β23% QoQ
Revenue: βΉ2,391 Cr β61% YoY | β19% QoQ
Other Income: βΉ14 Cr vs βΉ8 Cr YoY | βΉ8 Cr QoQ
EPS: βΉ8.26 β89% YoY | β24% QoQ
Net Profit: βΉ129 Cr β93% YoY | β23% QoQ
Revenue: βΉ2,391 Cr β61% YoY | β19% QoQ
Other Income: βΉ14 Cr vs βΉ8 Cr YoY | βΉ8 Cr QoQ
EPS: βΉ8.26 β89% YoY | β24% QoQ
β€2
IRIS CLOTHINGS Q2 FY27 (STANDALONE)
Net Profit: βΉ5 Cr β23% YoY | β27% QoQ
Revenue: βΉ62 Cr β40% YoY | β32% QoQ
EBITDA: βΉ9 Cr β34% YoY | β17% QoQ
EBITDA Margin: 15.1% vs 15.9% YoY | 17.0% QoQ
Net Profit: βΉ5 Cr β23% YoY | β27% QoQ
Revenue: βΉ62 Cr β40% YoY | β32% QoQ
EBITDA: βΉ9 Cr β34% YoY | β17% QoQ
EBITDA Margin: 15.1% vs 15.9% YoY | 17.0% QoQ
VARDHMAN SPECIAL STEELS Q2 FY27 (STANDALONE)
Net Profit: βΉ52 Cr β52% YoY | β27% QoQ
Revenue: βΉ600 Cr β39% YoY | β23% QoQ
Other Income: βΉ15 Cr vs βΉ11 Cr YoY | βΉ10 Cr QoQ
Operating Profit: βΉ69 Cr β53% YoY | β18% QoQ
Operating Profit Margin: 11.5% vs 10.5% YoY | 12.0% QoQ
EPS: βΉ5.42 β51% YoY | β28% QoQ
Net Profit: βΉ52 Cr β52% YoY | β27% QoQ
Revenue: βΉ600 Cr β39% YoY | β23% QoQ
Other Income: βΉ15 Cr vs βΉ11 Cr YoY | βΉ10 Cr QoQ
Operating Profit: βΉ69 Cr β53% YoY | β18% QoQ
Operating Profit Margin: 11.5% vs 10.5% YoY | 12.0% QoQ
EPS: βΉ5.42 β51% YoY | β28% QoQ
INDOCO REMEDIES Q2 FY27 (CONS.)
Net Profit: βΉ19.47 Cr vs βΉ9.21 Cr loss YoY | β70.25% QoQ
Revenue: βΉ520.17 Cr β7.32% YoY | β11.27% QoQ
EBITDA: βΉ46.43 Cr β7.85% YoY | β13.19% QoQ
EBITDA Margin: 8.93% vs 8.88% YoY | 8.77% QoQ
Other Income: βΉ2 Cr vs βΉ1 Cr YoY | βΉ2 Cr QoQ
EPS: βΉ2.11 β311% YoY | β70% QoQ
Net Profit: βΉ19.47 Cr vs βΉ9.21 Cr loss YoY | β70.25% QoQ
Revenue: βΉ520.17 Cr β7.32% YoY | β11.27% QoQ
EBITDA: βΉ46.43 Cr β7.85% YoY | β13.19% QoQ
EBITDA Margin: 8.93% vs 8.88% YoY | 8.77% QoQ
Other Income: βΉ2 Cr vs βΉ1 Cr YoY | βΉ2 Cr QoQ
EPS: βΉ2.11 β311% YoY | β70% QoQ
ACUTAAS CHEMICALS Q2 FY27 (CONS.)
Net Profit: βΉ123.14 Cr β71.37% YoY | β64.21% QoQ
Revenue: βΉ436.92 Cr β42.69% YoY | β32.53% QoQ
EBITDA: βΉ179.95 Cr β87.52% YoY | β185.31% QoQ
EBITDA Margin: 41.19% vs 31.34% YoY | 19.13% QoQ
Other Income: βΉ6 Cr vs βΉ8 Cr YoY | βΉ4 Cr QoQ
EPS: βΉ15.39 β74% YoY | β70% QoQ
Net Profit: βΉ123.14 Cr β71.37% YoY | β64.21% QoQ
Revenue: βΉ436.92 Cr β42.69% YoY | β32.53% QoQ
EBITDA: βΉ179.95 Cr β87.52% YoY | β185.31% QoQ
EBITDA Margin: 41.19% vs 31.34% YoY | 19.13% QoQ
Other Income: βΉ6 Cr vs βΉ8 Cr YoY | βΉ4 Cr QoQ
EPS: βΉ15.39 β74% YoY | β70% QoQ
ACUTAAS:
CO REVISE FY27 REVENUE GROWTH GUIDANCE UPWARD FROM 25% TO AROUND 30%. RAISING EBITDA MARGIN GUIDANCE TO 38-40% RANGE.
CO REVISE FY27 REVENUE GROWTH GUIDANCE UPWARD FROM 25% TO AROUND 30%. RAISING EBITDA MARGIN GUIDANCE TO 38-40% RANGE.